90 related articles for article (PubMed ID: 15343569)
1. Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: goodbye to coronary bypass grafting.
Colombo A
Catheter Cardiovasc Interv; 2004 Sep; 63(1):61-2. PubMed ID: 15343569
[No Abstract] [Full Text] [Related]
2. Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients--the Rotterdam experience.
Arampatzis CA; Hoye A; Lemos PA; Saia F; Tanabe K; Degertekin M; Sianos G; Smits PC; van der Giessen WJ; McFadden E; van Domburg R; de Feyter P; Serruys PW
Catheter Cardiovasc Interv; 2004 Sep; 63(1):57-60. PubMed ID: 15343568
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus-eluting stent implantation in a heart transplant recipient.
Tomai F; Gagliardi G; Proietti I
Ital Heart J; 2004 May; 5(5):408-9. PubMed ID: 15185909
[No Abstract] [Full Text] [Related]
4. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
Vijayakumar M; Lemos PA; Hoye A; Ong AT; Aoki J; Granillo GR; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Cummins PA; Serruys PW
Am J Cardiol; 2004 Oct; 94(7):909-13. PubMed ID: 15464675
[TBL] [Abstract][Full Text] [Related]
5. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
6. No delayed restenosis at 18 months after implantation of sirolimus-eluting stent.
Tanabe K; Degertekin M; Regar E; Ligthart JM; van der Giessen WJ; Serruys PW
Catheter Cardiovasc Interv; 2002 Sep; 57(1):65-8. PubMed ID: 12203931
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions.
Aziz S; Ramsdale DR
J Invasive Cardiol; 2005 Jan; 17(1):13. PubMed ID: 15640532
[No Abstract] [Full Text] [Related]
8. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
Ray GM; Nawarskas JJ; Frishman WH
Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
[TBL] [Abstract][Full Text] [Related]
9. Overstretching undersized drug-eluting stents: a temporary solution.
Bass TA
Catheter Cardiovasc Interv; 2004 Apr; 61(4):461-2. PubMed ID: 15065138
[No Abstract] [Full Text] [Related]
10. ARTS I -- the rapamycin eluting stent; ARTS II -- the rosy prophecy.
Serruys PW
Eur Heart J; 2002 May; 23(10):757-9. PubMed ID: 12009710
[No Abstract] [Full Text] [Related]
11. Drug-eluting stents for the prevention of restenosis: Standing the test of time.
Carter AJ
Catheter Cardiovasc Interv; 2002 Sep; 57(1):69-71. PubMed ID: 12203932
[No Abstract] [Full Text] [Related]
12. Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions.
Vijayakumar M; Rodriguez Granillo GA; Lemos PA; Aoki J; Hoye A; Ong AT; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Serruys PW
J Invasive Cardiol; 2005 Jan; 17(1):10-2. PubMed ID: 15640531
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of drug-eluting stents.
Williams DO; Kereiakes DJ
Rev Cardiovasc Med; 2005; 6 Suppl 1():S22-30. PubMed ID: 15665794
[TBL] [Abstract][Full Text] [Related]
14. New treatment for clogged coronary arteries.
Mayo Clin Health Lett; 2002 Dec; 20(12):4. PubMed ID: 12526107
[No Abstract] [Full Text] [Related]
15. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
17. Acute and intermediate-term procedural results using cypher stenting to treat multi-vessel coronary artery disease.
Kornowski R; Vaknin-Assa H; Assali A; Fuchs S
Int J Cardiovasc Intervent; 2005; 7(3):122-5. PubMed ID: 16243732
[TBL] [Abstract][Full Text] [Related]
18. Rotational ablation of an unexpandable sirolimus-eluting stent.
Hadjimiltiades S; Tsikaderis D; Louridas G
J Invasive Cardiol; 2005 Feb; 17(2):116-7. PubMed ID: 15687540
[No Abstract] [Full Text] [Related]
19. The conversion in application of percutaneous coronary intervention following the introduction of drug eluting stents.
Ikeno F; Raissi Shabari F; Sadoughi A; Lyons JK; Pourdehmobed K; Hashemi V; Emami S; Kaneda H; Yeung AC; Rezaee M
Int J Cardiol; 2006 Nov; 113(2):279-80. PubMed ID: 16318883
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus-eluting stents. (The results of the five-year use for the treatment of coronary artery disease).
Krylov AL
Angiol Sosud Khir; 2006; 12(4):71-82. PubMed ID: 17679960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
